metaLead
Developing a potent treatment for metal poisoning
metaLead has raised €1.2M across 2 funding rounds from 2 investors, most recently a round in May 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.2M
€1,222,663
Funding rounds
2
Investors
2
distinct backers
Active since
2023-03
latest 2025-05
Funding by year
EUR raised per yearmetaLead — funding by year — interactive chart.
Data table
| metaLead — funding by year | |
|---|---|
| 2023 | €153k |
| 2025 | €1.1M |
Signals
High confidenceRaise-next likelihood46
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-06 | Other | €1.1M | UZH Life Sciences Fund (LSF) | View deal → |
| 2023-03-10 | Other | €153k | Venture Kick | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData